Last Updated: Monday, June 22, 2015, 13:16
Shares of drugmaker Lupin rose by almost 2 percent after the stock became part of the BSE benchmark Sensex from on Monday.
Last Updated: Sunday, June 21, 2015, 12:18
Besides, a host of changes would also be effective in various other indices, where Adani Power would be dropped from the BSE 100 index.
Last Updated: Monday, June 1, 2015, 18:56
Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.
Last Updated: Tuesday, May 26, 2015, 14:10
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
Last Updated: Friday, May 22, 2015, 19:31
Private sector electricity producer Tata Power will move out of the stock market benchmark index Sensex and will be replaced by drugmaker Lupin.
Last Updated: Thursday, May 14, 2015, 18:52
On the NSE, it fell by 3.4 percent to settle at Rs 1,631.95.
Last Updated: Wednesday, May 13, 2015, 21:31
Drug major Lupin Wednesday announced acquisition of Brazil's Medquimica Industria Farmaceutica SA, marking its foray into the Latin American nation.
Last Updated: Wednesday, May 13, 2015, 16:59
Lupin scrip closed at Rs 1,690.60, down 3.35%, on the BSE.
Last Updated: Monday, April 20, 2015, 14:17
Zaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis).
Last Updated: Tuesday, March 24, 2015, 12:38
The Nifty rose after hitting nearly 1-1/2 month low on Tuesday as investors churned positions in defensive stocks such as Lupin Ltd from pharmaceutical sector on worries the record setting rally has run ahead of fundamentals.
Last Updated: Monday, March 16, 2015, 15:24
Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.
Last Updated: Monday, February 23, 2015, 15:42
The company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from the US Food and Drug Administration (USFDA).
more videos >>
